Sanara MedTech Inc. SEC filings SMTI

Sanara MedTech Inc. has 737 filings in SEC EDGAR's recent list, going back to May 2, 1996. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Sanara MedTech Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
425 Filing Oct 28, 2026 —
425 Current report Oct 16, 2026 —
8-K Current report
Other events
Oct 16, 2026 Oct 15, 2026
425 Current report Oct 16, 2026 —
8-K Current report
Shareholder vote results, Other events
Oct 1, 2026 Sep 30, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
DEFM14A Proxy statement Sep 4, 2026 —
425 Filing Aug 20, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
425 Filing Aug 11, 2026 —
425 Filing Aug 11, 2026 —
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
425 Filing Aug 11, 2026 —
8-K/A Amended current report
Material agreement, Regulation FD disclosure
Aug 11, 2026 Jul 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
425 Form 425 Jul 30, 2026 —
425 Form 425 Jul 30, 2026 —
425 Form 425 Jul 29, 2026 —
425 Form 425 Jul 29, 2026 —
425 Filing Jul 29, 2026 —
425 8-k Jul 29, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
425 Filing Jul 29, 2026 —
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
8-K Current report
Agreement ended
Jun 4, 2026 Jun 2, 2026
4 Insider transaction May 18, 2026 May 15, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
4/A Filing May 5, 2026 Mar 22, 2026
DEFA14A Additional proxy material Apr 17, 2026 —
ARS Annual report to shareholders Apr 17, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 17, 2026 —
DEF 14A Proxy statement Apr 17, 2026 Dec 31, 2025
4 Insider transaction Apr 16, 2026 Apr 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 14, 2026 —
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 10, 2026 Mar 7, 2026
4/A Filing Mar 9, 2026 Mar 1, 2026
4 Insider transaction Mar 2, 2026 Mar 1, 2026
8-K Current report
Regulation FD disclosure
Mar 2, 2026 Mar 2, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 6, 2026 —
8-K Current report
Results of operations
Jan 23, 2026 Jan 23, 2026
8-K Current report
Regulation FD disclosure
Nov 26, 2025 Nov 25, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 11, 2025
4 Insider transaction Sep 16, 2025 Sep 15, 2025
3 Initial insider ownership Sep 4, 2025 Aug 29, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2025 Aug 27, 2025
4 Insider transaction Aug 19, 2025 Aug 19, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
4 Insider transaction May 28, 2025 May 22, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 28, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
8-K Current report
Officer or director change
May 23, 2025 May 19, 2025
4 Insider transaction May 16, 2025 May 15, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Regulation FD disclosure
Apr 22, 2025 Apr 22, 2025
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 21, 2025 Dec 31, 2024
4 Insider transaction Apr 17, 2025 Apr 15, 2025
3 Initial insider ownership Apr 15, 2025 Apr 7, 2025
3 Initial insider ownership Apr 15, 2025 Apr 7, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Apr 4, 2025 Apr 1, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 22, 2025 Jan 15, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 22, 2025 Jan 16, 2025
3 Initial insider ownership Jan 21, 2025 Jan 15, 2025
8-K Current report
Results of operations
Jan 21, 2025 Jan 21, 2025
8-K Current report
Regulation FD disclosure
Dec 4, 2024 Dec 4, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
3 Initial insider ownership Oct 15, 2024 Oct 4, 2024
SC 13G Ownership over 5% (passive) Oct 8, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 7, 2024 Oct 4, 2024
8-K Current report
Officer or director change
Sep 23, 2024 Sep 19, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 11, 2024 Sep 10, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 26, 2024 —
8-K Current report
Regulation FD disclosure
Jun 20, 2024 Jun 20, 2024
8-K Current report
Officer or director change
Jun 18, 2024 Jun 12, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 17, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
EFFECT Filing May 31, 2024 —
8-K Current report
Officer or director change
May 30, 2024 May 29, 2024
CORRESP Letter to the SEC May 28, 2024 —
UPLOAD Letter from the SEC May 28, 2024 —
S-3 Shelf registration May 21, 2024 —
DEFA14A Additional proxy material May 15, 2024 —
DEFA14A Additional proxy material May 15, 2024 —
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations, Officer or director change
May 13, 2024 May 10, 2024
8-K Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
Apr 18, 2024 Apr 17, 2024
4 Insider transaction Apr 16, 2024 Apr 15, 2024
3 Initial insider ownership Apr 16, 2024 Apr 15, 2024
ARS Annual report to shareholders Apr 15, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 15, 2024 —
DEF 14A Proxy statement Apr 15, 2024 Apr 15, 2024
PRE 14A Preliminary proxy statement Apr 5, 2024 Apr 5, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 5, 2024 Apr 5, 2024
8-K Current report
Results of operations
Mar 25, 2024 Mar 25, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Bylaw or fiscal year change
Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
4 Insider transaction Sep 22, 2023 Sep 21, 2023
8-K Current report
Regulation FD disclosure
Sep 19, 2023 Sep 19, 2023
8-K Current report
Regulation FD disclosure
Aug 16, 2023 Aug 15, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
D Filing Aug 11, 2023 —
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure
Aug 2, 2023 Aug 1, 2023
8-K Current report
Shareholder vote results
Jun 6, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
3 Initial insider ownership Jun 5, 2023 Jun 1, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 Apr 21, 2023
4 Insider transaction Apr 14, 2023 Apr 12, 2023
4 Insider transaction Mar 21, 2023 Mar 17, 2023
4 Insider transaction Mar 21, 2023 Mar 17, 2023
4 Insider transaction Mar 21, 2023 Mar 17, 2023
8-K Current report
Results of operations
Mar 20, 2023 Mar 20, 2023
10-K Annual report Mar 20, 2023 Dec 31, 2022
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
8-K Current report
Material agreement
Feb 24, 2023 Feb 24, 2023
424B5 Prospectus supplement Feb 24, 2023 —
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Regulation FD disclosure
Dec 16, 2022 Dec 16, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
SMTI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Fort Worth, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
714256
Former names
WOUND MANAGEMENT TECHNOLOGIES, INC. (until Apr 3, 2019); MB SOFTWARE CORP (until Jun 10, 2008); INAV TRAVEL CORPORATION (until May 3, 1996)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.